Semarion
The company’s SemaCyte® Microcarrier Platform overcomes current limitations associated with adherent cell culture and assaying workflows by enabling small colonies of cells to be moved and frozen in their adherent state – increasing the volume of data collected per experiment and reducing the resource demands of in vitro drug discovery.
SemaCytes developed by Semarion are a novel class of cell carrier materials, created using microchip fabrication technologies, nanomagnetism, and smart materials.
These assaying microcarriers are flat and function as ultra-miniaturised, magnetically steerable wells which carry small colonies of adherent cells into suspension to improve cell-based experiments. They enable the controlled movement of cell types which need to stick to a surface, namely those typically used for in vitro drug discovery work.